Together, our data suggest that combined IL12-MSA and IL2-MSA promotes the activation and differentiation of SIY-reactive CD8+ T cells across multiple tissue sites, while restraining Tregs in tumor-bearing lungs. Here, IL2 is linked to neoplasm.